The Week In Cannabis: Stocks Outperform, Michigan Shapes Up As New Leader, Celeb Brands Get Hot

Saturday, 24 October 2020, 18:31:02
Cannabis stocks traded up in a relatively slow news week, where celebrity brands grabbed headlines. Chelsea Handler launched a curated cannabis products kit in collaboration with Sweet Flower . Cronos Group Inc. (NASDAQ: CRON ) and actress Kristen Bell partnered to launch Happy Dance, a CBD skincare brand. Uncle Bud’s , a hemp and CBD brand backed by Earvin “Magic” Johnson, launched in China via a partnership with Alibaba Group Holding Ltd – ADR (NYSE: BABA )’s Tmall. Over the five trading days of the week: The ETFMG Alternative Harvest ETF (NYSE: MJ ): gained 3.8% The AdvisorShares Pure Cannabis ETF (NYSE: YOLO ): was up 2.5% The Cannabis ETF (NYSE: THCX ): advanced 2.1% The Amplify Seymour Cannabis ETF (NYSE: CNBS ): closed the week up 1.6% The SPDR S&P 500 ETF Trust (NYSE: SPY ) was down 0.7% We also saw wholesale cannabis marketplace LeafLink release its October report looking into cannabis wholesale in the U.S. “The paper showed a 118% year-over-year (YoY) increase as measured by the company’s Gross Merchandise Value, which is the total value of merchandise sold over a certain period of time.
— Benzinga

Cronos Group (CRON) & The Competition Critical Contrast

Saturday, 24 October 2020, 13:18:37
Cronos Group (NASDAQ: CRON) is one of 36 public companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Cronos Group to related businesses based on the strength of its valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings. Insider and Institutional Ownership 12.1% of Cronos […]
— Stock Observer

Head-To-Head Analysis: Cronos Group (CRON) vs. Its Competitors

Saturday, 24 October 2020, 12:30:52
Cronos Group (NASDAQ: CRON) is one of 36 public companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Cronos Group to related companies based on the strength of its dividends, earnings, risk, institutional ownership, profitability, valuation and analyst recommendations. Earnings and Valuation This table compares Cronos […]
— Stock Observer

Comparing Cronos Group (CRON) and Its Competitors

Saturday, 24 October 2020, 10:12:47
Cronos Group (NASDAQ: CRON) is one of 36 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare Cronos Group to similar companies based on the strength of its valuation, analyst recommendations, profitability, risk, institutional ownership, dividends and earnings. Profitability This table compares Cronos Group and […]
— Dispatch Tribunal

Reviewing Cronos Group (CRON) & Its Rivals

Friday, 23 October 2020, 17:08:49
Cronos Group (NASDAQ: CRON) is one of 36 public companies in the “Medicinals & botanicals” industry, but how does it contrast to its competitors? We will compare Cronos Group to related companies based on the strength of its risk, valuation, analyst recommendations, profitability, dividends, institutional ownership and earnings. Profitability This table compares Cronos Group and […]
— Zolmax News